CyFlow CK-19 Biotin
| 品番 | CN002521 | ||
|---|---|---|---|
| 抗体名 | Anti-Hu CK-19 BIOTIN,BA-17 | ||
| 包装単位 | 0.1 mg | ||
| 濃度 | 1 mg/ml | ||
| 容量 | 0.1 ml | ||
| 関連製品 (アイソタイプコントロール) |
Mouse IgG1 Biotin (AQ807476) |
||
| 反応性|交差吸着 | Human | レーザー | |
| 抗原 | Cytokeratin 19 | 最大蛍光波長 | - |
| クローン | BA-17 | 最大励起波長 | - |
| ホスト | Mouse | 標識/Format | Biotin |
| アイソタイプ | IgG1 | 研究分野 | Cytoskeleton |
| クローナリティ | monoclonal | 用途 | Western blot |
Anti-Hu CK-19 BIOTIN,BA-17
特異性
The mouse monoclonal antibody BA-17 recognizes cytokeratin 19 in human tissue. Cytokeratin 19 (40 kDa) is not expressed in hepatocytes; it is often co-expressed with cytokeratin 7.
抗原情報
Cytokeratins are a subfamily of intermediate filaments and characterized by remarkable biochemical diversity. Cytokeratins are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individual cytokeratin polypeptides are designated 1 to 20 and divided into the type I (acidic cytokeratins 9-20) and type II (basic to neutral cytokeratins 1-8) families.
利用方法
The reagent is designed for Western blotting. Suggested working usage is 2 µg/ml. Indicated dilution is recommended starting point for use of this product, but working concentrations should be validated by the investigator.
保存方法
Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
安定性情報
Do not use after expiration date stamped on vial label.
レファレンス
• Bartek J, Durban EM, Hallowes RC, Taylor-Papadimitriou J: A subclass of luminal epithelial cells in the human mammary gland, defined by antibodies to cytokeratins. J·Cell·Sci. 1985·Apr; 75:17‑33. <·PMID:·2413060·>
• Bartek J, Taylor-Papadimitriou J, Miller N, Millis R: Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int·J·Cancer. 1985·Sep·15; 36(3):299‑306. <·PMID:·2411673·>
• Lewis BC, Klimstra DS, Varmus HE: The c‑myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes·Dev. 2003·Dec·15; 17(24):3127‑38. <·PMID:·14681205·>
Available Safety Data Sheets
CyFlow™ monoclonal antibodies SDS CA EN